Mestinon 180 MG timespan UU 30S
Ended Awarded
- Contract number
- SPE2DR26F8YZM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,785
Award facts
- Contract value 100% obligated
- $2,785.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $2,785.06, awards AmerisourceBergen Drug Corp the supply of Mestinon 180 mg Timespan in quantities of 30 units for the Defense Logistics Agency (DLA). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award, and is scheduled for completion by November 5, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Mestinon (pyridostigmine) is a cholinesterase inhibitor used primarily to treat myasthenia gravis and related neuromuscular disorders, reflecting the DLA's role in supplying specialized pharmaceuticals to support military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply an extensive portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The DLA's strategic approach involves establishing multiple regional Pharmaceutical Prime Vendor Global Program Generation V contracts, positioning AmerisourceBergen as a critical partner in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F8YZM?
SPE2DR26F8YZM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26F8YZM worth?
The government has obligated $2,785 on SPE2DR26F8YZM.
Is contract SPE2DR26F8YZM an order under another contract?
Yes. SPE2DR26F8YZM is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8YZM competed?
The extent of competition for SPE2DR26F8YZM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award